Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Chapple, C.R. orcid.org/0000-0002-2960-9931, Nitti, V.W., Khullar, V. et al. (5 more authors) (2014) Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World Journal of Urology, 32 (6). pp. 1565-1572. ISSN 0724-4983

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2014. This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Keywords: Mirabegron; Overactive bladder; beta(3)-Adrenoceptor agonist; Onset of action
Dates:
  • Published: 24 January 2014
  • Accepted: 15 January 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 May 2017 13:37
Last Modified: 02 May 2017 13:37
Published Version: http://doi.org/10.1007/s00345-014-1244-2
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s00345-014-1244-2
Related URLs:

Share / Export

Statistics